Donald Hsu

High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections

Levita Hidayat, Donald Hsu, Ryan Quist et al. · Archives of Internal Medicine · 2006 · 849 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

Donald Hsu, Levita Hidayat, Ryan Quist et al. · International Journal of Antimicrobial Agents · 2008 · 173 citations

Medicine, Infectious Diseases, Pharmacology +14

Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes

Donald Hsu, Mark P. Okamoto, Rekha Murthy et al. · Journal of Antimicrobial Chemotherapy · 2005 · 88 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Absolute Bioavailability and Intracellular Pharmacokinetics of Azithromycin in Patients with Cystic Fibrosis

Paul M. Beringer, Kitty My Tu Huynh, Jane Kriengkauykiat et al. · Antimicrobial Agents and Chemotherapy · 2005 · 58 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients

Donald Hsu, M. Hong Nguyen, Long H. Nguyen et al. · Journal of Antimicrobial Chemotherapy · 2010 · 56 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17